CHILDREN'S ADVIL-FLAVORED (ibuprofen) by GSK is cyclooxygenase inhibitors [moa]. First approved in 1996.
Drug data last refreshed 5h ago · AI intelligence enriched 1mo ago
Children's Advil-Flavored is an oral ibuprofen suspension approved for pediatric use, designed to reduce fever and relieve mild-to-moderate pain in children. It works by inhibiting cyclooxygenase enzymes, reducing prostaglandin synthesis and inflammation. The flavored formulation improves pediatric compliance compared to unflavored alternatives.
Product approaching loss of exclusivity with moderate competitive pressure (30%), suggesting portfolio defense and potential cost-focused strategies rather than growth initiatives.
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension
Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain
Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain
Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery
Ibuprofen Plus Acetaminophen for Enhanced Pain Reduction
Worked on CHILDREN'S ADVIL-FLAVORED at GSK? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on Children's Advil-Flavored offers limited career growth potential given its LOE-approaching status and commoditized market position. Roles focus on defensive brand management, retailer relationships, and cost optimization rather than launch momentum or innovation-driven advancement.